Timaran David E, Knowles Martyn, Ali Tarik, Timaran Carlos H
Division of Vascular and Endovascular Surgery, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Tex.
Division of Vascular and Endovascular Surgery, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Tex; University of North Carolina Rex Hospital, Raleigh, NC.
J Vasc Surg. 2017 Aug;66(2):354-359. doi: 10.1016/j.jvs.2016.11.064. Epub 2017 Feb 16.
Octogenarians with complex abdominal aortic aneurysms are at higher risk of death and morbidity after open repair. Fenestrated endovascular aneurysm repair (FEVAR) is an alternative to open repair for high-risk patients, such as octogenarians. The aim of this study was to evaluate perioperative and midterm outcomes of FEVAR among octogenarians at high and standard risk for open repair.
During a 2-year period, 85 patients (68 men [78%] and 17 women [22%]) underwent FEVAR using Zenith (Cook Medical, Bloomington, Ind) Fenestrated AAA Endovascular Grafts (70%), Zenith p-Branch (7%), and fenestrated custom-made devices (22%). Demographics and perioperative and follow-up outcomes of patients aged >80 years (n = 18 [21%]) and patients aged <80 years (n = 67 [79%]) were compared. The χ or Fisher test was used for categorical variables, and nonparametric tests were used for continuous variables. Kaplan-Meir curve was used for survival analysis.
Median age was 73 years (interquartile range [IQR], 68-79 years) for the entire cohort, 84 years (IQR, 81-86 years) among octogenarians, and 71 years (IQR, 67-75) for younger patients. Median aneurysm size was 56 mm (IQR, 53-62 mm). The median number of fenestrations was three. Preoperatively, octogenarians had higher Society for Vascular Surgery score (5.5 [IQR, 5-7] vs 5 [IQR, 3-6]; P = .01) and lower body mass index (26 [IQR, 21-27] vs 28 [24-32]; P = .04). Intraoperatively, technical success was 100% for both groups. The median operative time for octogenarians was 224 minutes (IQR, 160-272) vs 212 minutes (IQR, 177-281) in patients <80 years (P = .59). The median hospital length of stay was 3.5 days (IQR, 2-5) for octogenarians vs 4 days (IQR, 2-5) in younger patients (P = .87). Intensive care unit length of stay was 2 days for patients from both groups (IQR, 1-3). The rate of postoperative complications was 28% for octogenarians and 36% for patients aged <80 years (P = .5). None of the patients in this series required dialysis. No 30-day deaths occurred. The 20-month estimated survival rate was 75% in octogenarians and 91% in patients <80 years (P = .1). The rate of reinterventions at 20 months was 10% for octogenarians and 57% for younger patients (P = .09).
FEVAR is a safe and effective procedure in octogenarians at high and standard risk for open repair and those who are not eligible for standard endovascular aneurysm repair. Octogenarians have a similar technical success and low major adverse events similar to patients younger than 80 years.
患有复杂腹主动脉瘤的八旬老人接受开放修复术后死亡和发病风险更高。对于八旬老人等高风险患者,开窗腔内动脉瘤修复术(FEVAR)是开放修复术的一种替代方案。本研究的目的是评估在开放修复术高风险和标准风险的八旬老人中FEVAR的围手术期和中期结果。
在2年期间,85例患者(68例男性[78%]和17例女性[22%])接受了使用Zenith(库克医疗公司,印第安纳州布卢明顿)开窗型腹主动脉瘤腔内移植物(70%)、Zenith p分支(7%)和定制开窗装置(22%)的FEVAR。比较年龄>80岁患者(n = 18 [21%])和年龄<80岁患者(n = 67 [79%])的人口统计学、围手术期和随访结果。分类变量采用χ²检验或Fisher检验,连续变量采用非参数检验。采用Kaplan-Meir曲线进行生存分析。
整个队列的中位年龄为73岁(四分位间距[IQR],68 - 79岁),八旬老人为84岁(IQR,81 - 86岁),年轻患者为71岁(IQR,67 - 75岁)。中位动脉瘤大小为56 mm(IQR,53 - 62 mm)。开窗的中位数量为3个。术前,八旬老人的血管外科学会评分更高(5.5 [IQR,5 - 7]对5 [IQR,3 - 6];P = .01),体重指数更低(26 [IQR,21 - 27]对28 [24 - 32];P = .04)。术中,两组的技术成功率均为100%。八旬老人的中位手术时间为224分钟(IQR,160 - 272),年龄<80岁患者为212分钟(IQR,177 - 281)(P = .59)。八旬老人的中位住院时间为3.5天(IQR,2 - 5),年轻患者为4天(IQR,2 - 5)(P = .87)。两组患者的重症监护病房住院时间均为2天(IQR,1 - 3)。八旬老人的术后并发症发生率为28%,年龄<80岁患者为36%(P = .5)。本系列中无一例患者需要透析。无30天死亡病例。八旬老人20个月的估计生存率为75%,年龄<80岁患者为91%(P = .1)。八旬老人20个月时的再次干预率为10%,年轻患者为57%(P = .09)。
对于开放修复术高风险和标准风险且不符合标准腔内动脉瘤修复术条件的八旬老人,FEVAR是一种安全有效的手术方法。八旬老人与年龄小于80岁的患者具有相似的技术成功率和较低的主要不良事件发生率。